Enhancement of HIV Type 1 Antigen-Specific CD4+T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen
- 1 April 2000
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 16 (6) , 539-547
- https://doi.org/10.1089/088922200308954
Abstract
We examined HIV-1 specific memory helper T immune responses in chronically HIV-infected subjects who received an immune-based therapy (HIV-1 immunogen, Remune). Subjects in this study exhibited significant increases (p < 0.05) in the frequency of helper T memory cells expressing interferon gamma (IFN- gamma ) and tumor necrosis factor alpha (TNF- alpha ) in response to HIV-1 antigens in vitro. The frequencies of HIV-specific memory T cells increased after successive immunizations and exhibited a correlation with the standard tritiated thymidine incorporation lymphocyte proliferation assay (r = 0.72, p < 0.0008). These results support the notion that HIV-specific memory immune responses can be stimulated in subjects with chronic HIV infection. Further investigations are warranted to determine whether the induction of such responses is associated with virologic control.Keywords
This publication has 28 references indexed in Scilit:
- Phenotypic Analysis of Human Immunodeficiency Virus (HIV) Type 1 Cell‐Mediated Immune Responses after Treatment with an HIV‐1 ImmunogenThe Journal of Infectious Diseases, 1999
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.Journal of Clinical Investigation, 1997
- Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype RecombinantAIDS Research and Human Retroviruses, 1997
- Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, RitonavirThe Journal of Infectious Diseases, 1996
- Effect of Gamma Irradiation on the Human Immunodeficiency Virus and Human Coagulation ProteinsVox Sanguinis, 1989
- Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ERCell, 1989
- Human Immunodeficiency Virus Isolated from a Serum Sample Collected in 1976 in Central AfricaThe Journal of Infectious Diseases, 1987
- INVESTIGATIONS OF THE USE OF BETA‐PROPIOLACTONE IN VIRUS INACTIVATION*Annals of the New York Academy of Sciences, 1960